Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odunayo O Mugisho

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Experimental Eye Research|December 27, 2021
The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeuticsOdunayo O Mugisho, Colin R Green
Experimental Cell Research|September 10, 2021
Cell transdifferentiation in ocular disease: Potential role for connexin channelsJie Zhang, Colin R Green, Odunayo O Mugisho
Gels (Basel, Switzerland)|October 27, 2020
Characterization of Zinc Oxide Nanoparticle Cross-Linked Collagen HydrogelsYosra Agban, Odunayo O Mugisho, Sachin S Thakur, et al.
Drug Discovery Today|April 2, 2019
Depot formulations to sustain periocular drug delivery to the posterior eye segmentYosra Agban, Sachin S Thakur, Odunayo O Mugisho, et al.
Biomedicines|July 29, 2023
Comprehensive Grading System for Experimental Autoimmune Uveitis in MiceAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Drug Discovery Today|July 6, 2021
Blocking the inflammasome: A novel approach to treat uveitisAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Animal Models and Experimental Medicine|March 29, 2025
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitisAvik Shome, Ilva D Rupenthal, Rachael L Niederer, et al.
Acta Diabetologica|April 29, 2019
Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdownCharisse Kuo, Colin R Green, Ilva D Rupenthal, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 17, 2025
Gas-based therapies in chronic wounds: A scoping review of preclinical and clinical dataSrikar Kasha, Sara M Hanning, Odunayo O Mugisho, et al.
Experimental Physiology|June 19, 2026
Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat modelAimee R Mills, Antonio de Souza, Toan Pham, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Experimental Eye Research|December 27, 2021
The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeuticsOdunayo O Mugisho, Colin R Green
Experimental Cell Research|September 10, 2021
Cell transdifferentiation in ocular disease: Potential role for connexin channelsJie Zhang, Colin R Green, Odunayo O Mugisho
Gels (Basel, Switzerland)|October 27, 2020
Characterization of Zinc Oxide Nanoparticle Cross-Linked Collagen HydrogelsYosra Agban, Odunayo O Mugisho, Sachin S Thakur, et al.
Drug Discovery Today|April 2, 2019
Depot formulations to sustain periocular drug delivery to the posterior eye segmentYosra Agban, Sachin S Thakur, Odunayo O Mugisho, et al.
Biomedicines|July 29, 2023
Comprehensive Grading System for Experimental Autoimmune Uveitis in MiceAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Drug Discovery Today|July 6, 2021
Blocking the inflammasome: A novel approach to treat uveitisAvik Shome, Odunayo O Mugisho, Rachael L Niederer, et al.
Animal Models and Experimental Medicine|March 29, 2025
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitisAvik Shome, Ilva D Rupenthal, Rachael L Niederer, et al.
Acta Diabetologica|April 29, 2019
Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdownCharisse Kuo, Colin R Green, Ilva D Rupenthal, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 17, 2025
Gas-based therapies in chronic wounds: A scoping review of preclinical and clinical dataSrikar Kasha, Sara M Hanning, Odunayo O Mugisho, et al.
Experimental Physiology|June 19, 2026
Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat modelAimee R Mills, Antonio de Souza, Toan Pham, et al.
Pageof 4